OneThree Biotech scoops up $2.5 mn seed

New York-based OneThree Biotech, a biology-driven artificial intelligence platform that optimizes drug discovery and development, has secured $2.5 million in seed funding.

New York-based OneThree Biotech, a biology-driven artificial intelligence platform that optimizes drug discovery and development, has secured $2.5 million in seed funding. Primary Venture Partners and Meridian Street Capital led the round.

Source: Press Release